VHsquared
VHsquared has developed a platform of oral biologics – Vorabodies™ – for inflammatory bowel disease.
Vorabodies™ are oral gut-restricted domain antibodies directed at local immuno-inflammatory targets in the GI tract. Is in phase II trials in Crohn’s Disease with V565
